CYT   $3.1  -2.59% Market Closed

Cyteir Therapeutics Inc
Total Cash 129.24M
totalCashPerShare 3.591
EBITDA -33.41M
Total Debt 16.00K
quickRatio 21.655
currentRatio 21.887
Total Revenue
debtToEquity 0.013
Revenue/Share
ROA -0.145
ROE -0.23805
grossProfits
freeCashflow -14.30M
operatingCashflow -25.79M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -20.89M
forwardPE
floatShares 10.83M
sharesOutstanding 36.00M
sharesShort 319.73K
sharesShortPriorMonth 345.80K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.77%
Short Ratio help_outline 3.07%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 3.466
Price To Book help_outline 0.87
earningsQuarterlyGrowth
netIncomeToCommon -33.22M
trailingEps -0.93%
forwardEps -0.87%
enterpriseToEbitda 0.62
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2023
institutionsCount 51
lastUpdated April 1, 2024, 3:12 p.m.